共 50 条
- [21] APRIL in systemic lupus erythematosus: Essential or dispensable? Comment on the article by Jacob et al ARTHRITIS AND RHEUMATISM, 2012, 64 (06): : 2052 - 2053
- [22] Thrombovascular events in systemic lupus erythematosus: comment on the article by Jung et al Reply ARTHRITIS AND RHEUMATISM, 2010, 62 (09): : 2824 - 2825
- [23] Estimates of the US prevalence of systemic lupus erythematosus: comment on the article by Lawrence et al ARTHRITIS AND RHEUMATISM, 1999, 42 (02): : 396 - 396
- [24] Systemic lupus erythematosus in patients native to West and Central Africa: comment on the article by Bae et al - Reply ARTHRITIS AND RHEUMATISM, 1999, 42 (07): : 1561 - 1561
- [25] Hydroxychloroquine blood assay as a marker of nonadherence in patients with systemic lupus erythematosus: comment on the article by Koneru et al ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (01): : 153 - 153
- [26] Increased levels of interleukin-18 in patients with systemic lupus erythematosus: comment on the article by Shibatomi et al ARTHRITIS AND RHEUMATISM, 2002, 46 (05): : 1410 - 1411
- [27] Epigenetic considerations in investigating the cause of systemic lupus erythematosus: comment on the article by Chagnon et al ARTHRITIS AND RHEUMATISM, 2007, 56 (03): : 1035 - 1035
- [28] Posterior reversible encephalopathy syndrome in systemic lupus erythematosus: comment on the article by Efthimiou et al ARTHRITIS AND RHEUMATISM, 2011, 63 (01): : 309 - 309
- [29] APRIL in systemic lupus erythematosus: essential or dispensable? Comment on the article by Jacob et al Reply ARTHRITIS AND RHEUMATISM, 2012, 64 (06): : 2053 - 2054
- [30] Mycophenolate mofetil in the treatment of systemic lupus erythematosus: comment on the article by Hervier et al Reply ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : 3489 - 3490